Hans-Peter Gerber
Technik-/Wissenschafts-/F&E-Leiter bei SUTRO BIOPHARMA, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Hans-Peter Gerber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SUTRO BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.09.2023 | - |
T-CURX GmbH | Vorsitzender | - | - |
Karriereverlauf von Hans-Peter Gerber
Ehemalige bekannte Positionen von Hans-Peter Gerber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Direktor/Vorstandsmitglied | 01.01.2017 | 01.01.2021 |
Independent Dir/Board Member | 01.01.2017 | 01.01.2021 | |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Direktor/Vorstandsmitglied | 01.01.2016 | 01.01.2018 |
Präsident | 01.01.2016 | 01.01.2018 |
Ausbildung von Hans-Peter Gerber
University of Zurich | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Schweiz | 3 |
Deutschland | 2 |
Operativ
Director/Board Member | 2 |
President | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SUTRO BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
T-CURX GmbH |
- Börse
- Insiders
- Hans-Peter Gerber
- Erfahrung